Search

everythinglearnresearchcommunity

for

Search:↓

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Low vitamin D levels are linked to severe and active alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Phototherapy can help treat hair loss in alopecia areata.

A child used a hair growth lotion for hair loss, but it caused excessive hair growth on his face and neck instead.

A scalp infection can look like alopecia areata and get worse if treated incorrectly.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Asthisrinkala lepa is more effective than Triphala mashi lepa for treating Alopecia areata.

Topical sensitizers have mixed success in treating alopecia areata.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Quercetin effectively treated and prevented hair loss in mice.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.